Company Announcements

Transaction in Own Shares

Source: RNS
RNS Number : 2805F
Dunelm Group plc
04 November 2022

4 November 2022




Transaction in own shares



Dunelm Group plc (the "Company") announces that on 3 November 2022 it purchased the following number of ordinary shares of 1 pence each in the Company pursuant to its share repurchase

Programme, details of which were announced on 26 September 2022:


Date of purchase:

3 November 2022


Number of ordinary shares purchased:



Highest price paid per share:



Lowest price paid per share:



Volume weighted average price paid:




Barclays Capital Securities Limited



The purchased shares will be held in treasury and may be utilised to satisfy employee share-based award obligations.


Including Shares which have been purchased but not yet settled, the Company holds 2,345,382 shares in treasury.

Following the purchase of these shares, the Company's issued ordinary share capital consists of 203,426,835 ordinary shares of which a total of 2,345,382 shares are held in treasury, including shares which have been purchased but not yet settled. Therefore, the total number of ordinary shares with voting rights in the Company is 201,081,453 ordinary shares.

The above figure of 201,081,453 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (also in force in the UK, from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades is available through the link below:


For further information please contact: 

Dunelm Group plc

Dawn Durrant, Company Secretary

MHP Communications

Simon Hockridge/ Rachel Farrington/

Pete Lambie



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.